期刊文献+

IAP家族分子与肿瘤靶向治疗 被引量:13

IAP family and IAP-targeted cancer therapy
原文传递
导出
摘要 凋亡抑制因子(inhibitor of apoptosis proteins,IAPs)是一类高度保守的内源性抗细胞凋亡因子家族,主要通过抑制Caspase活性和参与调节核因子NF-κB的作用而抑制细胞凋亡。细胞抗凋亡机制在肿瘤发生、发展以及肿瘤耐药性形成中发挥重要作用。肿瘤细胞高表达IAPs是导致肿瘤细胞抵抗凋亡的关键。细胞凋亡调控异常与肿瘤细胞耐药密切相关,增强肿瘤细胞对化疗药物的敏感性成为近年来肿瘤治疗的重要策略之一。该文综述了IAP家族蛋白的结构、生物学特性及其作为肿瘤治疗靶点的研究进展。 The inhibitor of apoptosis proteins(IAPs) are known as a group of highly conserved endogenous proteins that regulate the activity of caspases and NF-kB survival pathways.The mechanism of resistant apoptosis has played a crucial role in the tumorigenesis,tumor progress and drug resistance.Overexpression of IAPs has been shown to confer protection against a number of apoptosis in a variety of stress and is believed to have important consequences with respect to human cancer.Deregulation of apoptosis is associated to tumor resistance to chemo therapeutic agents.Enhanced chemosensitivity of tumor cells is one of importanttherapeutic strategies for cancer therapy.This review will focus on biological characteristics and the structure of IAP proteins,and IAP-targeted therapies for cancer treatment.
作者 许杨 赵晓航
机构地区 中国医学科学院
出处 《生命科学》 CSCD 北大核心 2010年第2期161-168,共8页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(30428011 30772507) 国家高技术发展计划“(863”计划)(2006AA02A403 2006AA02A308) 国际科技合作与交流专项(2008DFA31130)
关键词 IAP 凋亡 肿瘤 化疗敏感性 IAP apoptosis tumor chemosensitivity
  • 相关文献

参考文献55

  • 1Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell, 1995, 80 (1): 167-78.
  • 2LaCasse EC, Mahoney D J, Cheung HH, et al. IAP-targeted therapies for cancer. Oncogene, 2008, 27 (48): 6252-75.
  • 3Bertrand MJ, Milutinovic S, Dickson KM, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligasesthat promote RIP1 ubiquitination. Mol Cell, 2008, 30 (6): 689-700.
  • 4Dai Z, Zhu WG, Morrison CD, et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis clAP1 and clAP2 as candidate oncogenes. Hum Mol Genet, 2003, 12 (7): 791-801.
  • 5Fong WG, Liston P, Rajcan-Separovic E, et al. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics, 2000, 70 (1): 113-22.
  • 6Konopka K, Spain C, Yen A, et al. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells. Cell Mol Biol Lett, 2009, 14 (1): 70-89.
  • 7Franklin MC, Kadkhodayan S, Ackerly H, et al. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry, 2003, 42 (27): 8223-31.
  • 8Eckelman BP, Drag M, Snipas S J, et al. The mechanism of peptide-binding specificity of IAP BIR domains. Cell Death Differ, 2008, 15 (5): 920-8.
  • 9Vaux DL, Silke J. lAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol, 2005, 6 (4): 287-97.
  • 10Plenchette S, Cathelin S, Rebe C, et al. Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event. Blood, 2004, 104 (7): 2035-43.

同被引文献156

引证文献13

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部